Yuyu Pharma Publishes History for 80th Anniversary
The history of Yuyu's challenges and changes during the past 80 years as a first-generation pharmaceutical company will be composed in storytelling format
The history of Yuyu's challenges and changes during the past 80 years as a first-generation pharmaceutical company will be composed in storytelling format
Presentazione di Aerovac: importante fornitore/produttore di materiali di lavorazione e utensili
ZURICH, March 2, 2021 /PRNewswire/ -- TBY Holding, a newly founded investment holding company that has recently purchased 75% shares of Europe's largest biomass energy facility plant, has acquired the sole exclusive Intellectual Property Brokerage Rights of 128 pharmaceutical patents invented by Erdal Can Alkoclar and Metehan Yesil.
MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing
BRUSSELS and ATLANTA, Feb. 23, 2021 /PRNewswire/ --
LEUVEN, Belgium and BOSTON, Feb. 23, 2021 /PRNewswire/ -- icometrix, world leader in imaging AI solutions for people with neurological conditions, announced the addition of icobrain cva, a stroke solution, to the icobrain portfolio. The announcement follows the FDA-clearance and CE-marking of its image processing software for the analysis and communication of the tissue perfusion state on computer tomography (CT) perfusion scans in patients with ischemic stroke. icobrain cva provides physicians w...
LACHEN, Switzerland, Feb. 22, 2021 /PRNewswire/ -- Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis (Liesner RJ et al. "Simoctocog Alfa (Nuwiq®) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study" https://www.thieme-connect.com/products/ejournals/abstra...
Patient complexity is on the rise(1) and surgeons need a high-quality material for hernia repair in complex patients (VHWG 2).(2)
VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ -- Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (TSX: WLLW.WT) (OTCQX: CANSF) is pleased to announce that it has closed its previously announced upsized bought deal offering of 17,424,800 common shares (the "Common Shares") of the Company at a price of $1.65 per Common Share, which includes 2,272,800 Common Shares issued pursuant to the exercise in full of the over-allotment option, for aggregate gross proceeds of approximately $28.75 m...
DÜSSELDORF, Germany, Feb. 18, 2021 /PRNewswire/ -- Gerresheimer AG posted strong growth in the fourth quarter of 2020 and landed inside the target range despite the negative impact of the COVID-19 pandemic. "Business in the fourth quarter was very strong. It was the best quarter in the Company's history. Despite the negative impact of the coronavirus pandemic, especially in our cosmetics business, we reached our goals for 2020. The successful acceleration of growth in large parts of our core busi...
PARIGI, 16 febbraio 2021 /PRNewswire/ -- Sebbene ogni anno colpisca più di 140.000 bambini, il noma rimane una malattia pressochè sconosciuta per il grande pubblico. Derivata dal greco "nomein", che significa "divorare", la malattia distrugge il viso, causando la morte del bambino nel 90% dei casi. Per combattere questo flagello, nel 2019, l'ex calciatore Roger Milla ha fondato l'associazione Noma Fund. Insieme a ex giocatori internazionali come Joseph-Antoine Bell, François Omam-Biyik, Patrick M...
LONDON, Feb. 10, 2021 /PRNewswire/ -- Medicom Healthcare Limited (Medicom) and Famar Health Care Services Madrid (Famar) are pleased to announce the signing of an Asset Purchase Agreement (APA) for the acquisition by Medicom of the pharmaceutical dossier of BIMATOPROST 0.3 mg/mL, 3ml, preservative free eye drop solution, developed by Famar R&D. Under this agreement, Medicom has acquired the ownership of the product dossier which is already registered in the UK and 5 EU countries with plans to com...
Business transformation continues to gain traction
Potential to receive up to $103 million in upfront and milestone payments, in addition to royalties and other payments
HANGZHOU, China, Feb. 5, 2021 /PRNewswire/ -- Over 60 percent of respondents held a positive attitude toward the prospects of China's healthcare system and the potential for technologies, a health report found.
Gran parte delle cure chemioterapiche e delle cure di supporto è off patent.
SUZHOU, China, Feb. 2, 2021 /PRNewswire/ -- CF PharmTech, Inc. is a fully integrated pharmaceutical company in China specializing in the treatment of respiratory diseases. Chengdu Shangyi Information Technology Co., Ltd is a professional IT service company in the healthcare industry in China.
GUANGZHOU, China, Feb. 1, 2021 /PRNewswire/ -- Wondfo is ramping up neutralizing antibody, antigen and PCR tests to address the evolving demands for COVID-19 testing globally. As countries draw up plans to deal with the new wave of infections amidst the pandemic while vaccination programmes are rolled out, Wondfo remains resolute and agile to provide healthcare authorities with the specific tests they need to apply appropriate testing strategies that can help bring the pandemic under control.
TOKYO, Jan. 29, 2021 /PRNewswire/ -- The winners of the 2021 Japan Prize were announced on January 29 by the Japan Prize Foundation and its president, Hiroshi Komiyama. The newest laureates are Australian researcher Prof. Martin Andrew Green, honored for his work in the field of "Resources, Energy, the Environment, and Social Infrastructure," and U.S. researchers Prof. Bert Vogelstein and Dr. Robert A. Weinberg, joint winners for their work in the field of "Medical Science and Medicinal Science."...
